Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
65.70 GBX | +0.77% |
|
+0.46% | +2.66% |
24/06 | IDOX plc, H1 2025 Earnings Call, Jun 12, 2025 | |
12/06 | IDOX plc Reports Earnings Results for the Half Year Ended April 30, 2025 | CI |
Highlights: IDOX plc
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses: IDOX plc
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 36.53 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 3.35 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings Chart: IDOX plc
Source: Surperformance
ESG chart: IDOX plc
Source: MSCI
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
41Cr | |||||
66TCr | |||||
36TCr | |||||
21TCr | |||||
7.67TCr | |||||
- | 3.87TCr | ||||
2.96TCr | |||||
2.58TCr | |||||
2.44TCr | |||||
Average | 15.9TCr | ||||
Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
A
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- IDOX Stock
- Ratings IDOX plc
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition